Another company is developing a two month slow release implant of a generic dopamine agonist to treat Parkinson's.
Per their 10K: they held a meeting with the FDA and "based on this meeting, we believe that we can submit an NDA under Section 505(b)(2) of the FDCA and that the FDA may require only a single successful pivotal Phase III clinical trial for approval."
Can Titan run one P3 trial to get their ProNeura implant approved?
What is Sunil waiting for?
Titan has $17 million. Why not advance the Parkinson's program?
He will burn all the cash in a year and shareholders will have nothing to show for it.
He had that opportunity and screwed it up. Why management gets defended on this board for blunder after blunder is amazing but many long time holders seem to love these guys that have destroyed the company. They act like they are getting a response from some great celebrity sage when Sunil gifts them an e-mail response. Just another example of buyer beware in the investment world. We had a potential money making first to market product and our management failed to get it to market. As Buffet says he likes to invest in companies any fool can run because sooner or later there will be one in charge. The beat goes on at TTNP.